Anesthetic effects of the ketamine and midazolam association by intranasal or intramuscular route in domestic chickens: prospective, blinded, randomized and crossover study.
Fernanda Meirelles AdãoIsabella Danon MartinsÁlvaro Alberto Moura Sá Dos PassosRenata Fernandes Ferreira de MoraesDaniel de Almeida BalthazarEduardo Butturini de CarvalhoPublished in: Brazilian journal of veterinary medicine (2024)
This prospective, blinded, randomized crossover study aimed to assess the anesthetic effects of the combination of 30 mg/kg ketamine and 2 mg/kg midazolam via intranasal (IN) or intramuscular (IM) routes in twelve domestic chickens. Physiological parameters (respiratory rate - RR, heart rate - HR, and cloacal temperature -Tºcloacal) were monitored throughout the experiment, along with recovery time and sedation level (S0: awake, no recumbency, responsive to stimuli; S1: blinking eyes, recumbency, relaxed, response to stimulus, mild movement; S2: open eyes, recumbency, relaxed, mild response to stimuli; S3: closed eyes, recumbency, relaxed, no movement). In the IM group, all birds reached S3, while in IN 5/12 reached S3, 4/12 reached at most S1, and 1/12 at most S2. IM administration showed higher sedation at 5, 10, 15, 20, 30, 35, 40, and 45 minutes (p<0.05). IN administration exhibited a shorter total recovery time (26.3±21.4 min vs. 92.9±33.4 min; p<0.001). No time, group, or time-group interaction effects were observed in HR and cloacal Tº, with a trend to a decrease in RR both groups (p<0.001). Increased incidences of vocalization and agitation was observed via IM (4/12 vs. 0/12; p=0.028), with no difference in salivation. Despite faster recovery with less agitation and vocalization, the ketamine and midazolam combination via IN provided less consistent sedation compared to the IM route in chickens.
Keyphrases
- heart rate
- placebo controlled
- optical coherence tomography
- double blind
- heat stress
- open label
- heart rate variability
- pain management
- phase iii
- mechanical ventilation
- blood pressure
- phase ii
- study protocol
- disease virus
- clinical trial
- minimally invasive
- cataract surgery
- randomized controlled trial
- deep brain stimulation
- cancer therapy
- drug delivery